Insider Trading activities at Caris Life Sciences, Inc. (CAI)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Caris Life Sciences, Inc. (CAI) since 2025 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Caris Life Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2019410.

Total stock buying since 2025: $787,500.
Total stock sales since 2025: $0.
Total stock option exercises since 2025: $488,000.


4 insiders reported insider trading activities at Caris Life Sciences, Inc. (CAI):
Insider trading activities of Poste George
Insider trading activities of Spetzler David Baxley
Insider trading activities of Denton John Russel
Insider trading activities of Brille Brian J

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Caris Life Sciences, Inc. (CAI).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 37,500 $787,500 0 $0 200,000 $488,000

Table 2. Monthly summary of insider trading at Caris Life Sciences, Inc. (CAI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 0 $0 0 $0 125,000 $305,000
2025-06 37,500 $787,500 0 $0 75,000 $183,000

Table 3. Detailed insider trading at Caris Life Sciences, Inc. (CAI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-11 Poste George Option Ex 125,000 2.44 305,000
2025-06-20 Brille Brian J (See Remarks) Buy 30,000 21.00 630,000
2025-06-20 Spetzler David Baxley (President) Option Ex 75,000 2.44 183,000
2025-06-20 Denton John Russel (See Remarks) Buy 7,500 21.00 157,500

Insider trading activities including stock purchases, stock sales, and option exercises of CAI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Caris Life Sciences, Inc. (symbol CAI, CIK number 2019410) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.